Overview: Oligoclonal Bands IgG TestIntroduction: The Oligoclonal Bands IgG Test detects oligoclonal bands to diagnose multiple sclerosis, causing weakness or vision issues. Aligned with 2023 AAN guidelines, it uses PCR for high specificity, supporting neurological screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in molecular pathology for patients with suspected multiple sclerosis (MS).
Other Names: Oligoclonal Bands Assay, MS CSF Test.
FDA Status: Laboratory-developed test (LDT), meeting molecular pathology standards for diagnostic accuracy.
Historical Milestone: Oligoclonal band testing began in the 1970s with MS research. PCR methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects oligoclonal bands to diagnose multiple sclerosis, guides treatment, and evaluates patients with weakness or vision issues.
Test Parameters: 1. Oligoclonal Bands IgG
Pretest Condition: No fasting required. Collect CSF and serum. Report history of weakness, vision issues, or MS symptoms.
Specimen: CSF (sterile container, 1-2 mL), Serum (SST, 2-5 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document weakness, vision issues, numbness, or family history of MS. Include current medications, especially immunomodulators.
Consent: Written consent required, detailing the tests purpose, MS implications, and risks of lumbar puncture for CSF collection.
Procedural Considerations: Uses PCR and electrophoresis to detect oligoclonal bands in CSF compared to serum. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for MS diagnosis.
Factors Affecting Result Accuracy: Improper CSF collection or contamination can affect results. Serum contamination in CSF may reduce specificity.
Clinical Significance: Presence of oligoclonal bands confirms MS, guiding immunomodulatory therapy. Negative results may require MRI confirmation.
Specialist Consultation: Consult a neurologist for result interpretation and treatment planning.
Additional Supporting Tests: Brain MRI, evoked potentials, or CSF IgG index to confirm MS diagnosis.
Test Limitations: Not all MS cases show oligoclonal bands; clinical correlation is needed. Sample quality affects sensitivity.
References: AAN MS Guidelines, 2023; Neurology, Thompson AJ, 2022.
